期刊文献+

对药用辅料监管现状的几点思考 被引量:4

Pondering over Pharmaceutical Excipients Regulation
下载PDF
导出
摘要 目的为建立符合我国制药行业发展的药用辅料监管方式提供参考。方法对我国药用辅料的标准收载情况、行业以及行政管理现状进行分析,在借鉴欧美国家药用辅料监管经验的基础上,提出相应的监管对策。结果与结论我国药用辅料行业存在法律法规体系缺失、质量标准不健全、行业准入门槛低、质量保证体系缺失等监管漏洞,建议通过建立健全相关法律法规、完善药用辅料备案档案(DMF)备案管理、实行第三方审计和建立制药企业辅料数据库等措施,加强我国药用辅料监管,确保药用辅料质量安全。 Objective To provide reference for pharmaceutical excipients regulation in accordance with the development of domestic pharmaceutical industry. Methods The current status of standard compilation, industry development and administration systems of pharmaceutical excipients were analyzed, corresponding countermeasures were offered on the basis of reference to experience of excipients regulation in European and American countries. Results and Conclusion The analysis revealed that there were still many loopholes existing in the pharmaceutical excipients industry, such as lack of laws and regulation systems, incomplete quality standards, a low entry-level, as well as lack of a quality assurance system. It is recommended to establish and improve relevant laws and regulations, improve DMF filing management, practice the third-party audit system and establish excipient database of pharmaceutical companies to strengthen the supervision of pharmaceutical excipients, and ensure quality and safety of pharmaceutical excipients.
出处 《中国药事》 CAS 2013年第10期1025-1028,1036,共5页 Chinese Pharmaceutical Affairs
关键词 药用辅料 管理现状 法律法规 质理标准管理 对策 pharmaceutical excipients management status law and regulations quality standard management countermeasures
  • 相关文献

参考文献15

  • 1张龙涛,梁毅.我国药用辅料标准中存在的问题及改进对策[J].上海医药,2007,28(12):537-538. 被引量:12
  • 2宋民宪,夏军平.部分省市药用辅料使用情况调研报告[J].首届药用辅料(国际)学术研讨会论文集,2004.
  • 3安徽省医药行业协会.我国药用辅料的产业现状及发展趋势[EB/OL]. [2011-11 -20]. http: //www. ah ppa. cn/por- tal. php? mod=viewaid=355.
  • 4国际药用辅料网.对我国药用辅料工业发展的浅见[EB/OL].[2009-03 12]. http: /,/www. phexcorru cn/bbs/Index, asp.
  • 5刘晓丹,杨悦.我国药用辅料管理中存在的问题及应对策略[J].中国新药杂志,2012,21(13):1448-1452. 被引量:7
  • 6国家食品药品监督管理总局.关于印发加强药用辅料监督管理有关规定的通知[EB/OL].[2012-08-01].http://www.sda.gov,ca/WS01/Ci.0844/73959.html.
  • 7国家食品药品监督管理局.关于《药用辅料管理办法》(征求意见稿)网上征求意见的函[EB/OL].[2011-02-21].ht-tp://www.sda.gov.cn/WS01/CL0055/10420.html.
  • 8宋民宪.药用辅料配角时代的消亡[N].医药经济报,2008-06-07(011).
  • 9张庆生.完善药品标准体系建设,关注药用辅料标准[J].中国药师,2005,8(12):1034-1035. 被引量:6
  • 10马兰,王欢,Justin Uratani,郑强.中美欧药用辅料监管比较分析[J].中国新药杂志,2012,21(22):2612-2622. 被引量:7

二级参考文献53

  • 1史晓伟.美国“公认安全使用物质”(GRAS)法规简介[J].中国食品添加剂,2009,0(S1):42-47. 被引量:9
  • 2佘清.中国药用辅料的监管问题浅析[J].中国药品标准,2006,7(6):66-69. 被引量:10
  • 3全球药用辅料启示录[EB/OL].[2011-11-14].http://www.ce.cn/yiyao/gjgc/scdt/20041I/08/t20041108_2218231.shtml.
  • 4国家食品药品监督管理局.中华人民共和国药品管理法[M].北京:中国医药科技出版社,2006:25.
  • 5美国药典(USP)网站.美国药典-国家处方集(USP-NF)[EB/OL].[2011-03一01].http://www.usp.org/pdf/EN/USPNF/chapter3.pdf.
  • 6ROBERTSONM.Regulatoryissueswithexcipients[J].mJPhdm,1999,187(2):273-276.
  • 7国家食品药品监督管理局.关于《药用辅料管理办法》(征求意见稿)网上征求意见的函[EB/OL].[2011-02-21].ht-tp://www.sda.gov.cn/WS01/CL0055/10420.html.
  • 8WHO. WHO Expert Commitee on specifications for pharmaceutical preparations: thirty-eighth report. WHO Technical Report Series 917, 2003. [R/OL]. [2011-03 -01]. http://whqlibdoc, who. int/trs/WI-IO TRS 917_annex2. pdf.
  • 9JACKSON K, YOUNG D,PANTS. Drug-excipient interactions and their affect on absorption [ J ]. Pharm Sci Techno Today, 2000,3 ( 10 ) : 336 - 345.
  • 10WANG FJ,SAIDELMG, GAO JM. A mechanistic model of con- trolled drug release from polymer millirods: Effects of excipients and complex binding [ J ]. J Controlled Release, 2007,119 ( 1 ) : 111 - 120.

共引文献34

同被引文献37

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部